Amlodipine Besylate
Product Images NDC 45865-810

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 45865-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (810)

Pdp (810)
AMLODIPINE BESYLATE TABLETS 10MG blister card label. The label indicates the product is generic for Norvasc, contains 100 tablets, and advises caution regarding dizziness and drowsiness. It includes instructions to avoid alcohol and to take as directed by a physician. The labeler is Medsource Pharmaceuticals.*
FDA Label Image

Image (D698c8a7 4f80 459d Bf68 Ee01a3634bac 01)

Image (D698c8a7 4f80 459d Bf68 Ee01a3634bac 01)
Chemical structure diagram of amlodipine besylate showing its molecular formula and atomic connectivity, including rings, functional groups, and atoms such as chlorine, oxygen, nitrogen, carbon, and sulfur, consistent with the drug's known chemical composition.*
FDA Label Image

Image2 (D698c8a7 4f80 459d Bf68 Ee01a3634bac 02)

Image2 (D698c8a7 4f80 459d Bf68 Ee01a3634bac 02)
A line graph comparing event rates over time (up to 24 months) between Amlodipine and placebo groups. The x-axis shows time in months, and the y-axis shows event rate. Two lines represent the Amlodipine and placebo groups, with the placebo group showing a higher event rate over time. The graph includes a statistical summary with a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval of 0.54 to 0.88.*
FDA Label Image

Image3 (D698c8a7 4f80 459d Bf68 Ee01a3634bac 03)

Image3 (D698c8a7 4f80 459d Bf68 Ee01a3634bac 03)
A forest plot displaying hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across patient subgroups including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI-stent strata. The horizontal axis represents hazard ratio values from 0.0 to 2.0, with data points primarily favoring Amlodipine. The plot provides subgroup analysis results related to Amlodipine treatment effects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.